financetom
Business
financetom
/
Business
/
Health insurers slide after Trump targets Obamacare subsidies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Health insurers slide after Trump targets Obamacare subsidies
Nov 10, 2025 5:57 AM

(Reuters) -Shares of health insurers with plans under the Affordable Care Act, or Obamacare, fell 7% to 1.5% premarket on Monday after U.S. President Donald Trump said federal funds subsidizing those plans must be redirected to Americans buying coverage.

The subsidies, which are due to expire at the end of the year, were introduced during the COVID-19 pandemic to help lower-income Americans pay for private health insurance and are at the heart of the longest-ever federal shutdown that has sidelined federal workers, delayed food aid and snarled air travel.

Trump posted on his Truth Social platform on Sunday, blasting the subsidies as a "windfall for Health Insurance Companies, and a DISASTER for the American people". He repeated a call for funds to be sent directly to individuals to buy coverage on their own.

"I stand ready to work with both Parties to solve this problem once the Government is open," Trump said in the post.

Shares of Centene slid 7.1%, Molina Healthcare slipped 1.5%, Elevance Health was down 3.4%, while UnitedHealth fell 1.7% in trading before the bell.

"I am recommending to Senate Republicans that the Hundreds of Billions of Dollars currently being sent to money sucking Insurance Companies in order to save the bad Healthcare provided by ObamaCare, BE SENT DIRECTLY TO THE PEOPLE SO THAT THEY CAN PURCHASE THEIR OWN, MUCH BETTER, HEALTHCARE, and have money left over," Trump had said in an earlier post on Saturday.

Obamacare plans are subsidized by the government based on income and include a risk-adjustment pool that reimburses insurers covering a disproportionate share of sicker members.

Democrats want to extend the subsidies before reopening government, while Republicans said they would be open to addressing the issue only after government funding was restored.

The subsidies have enabled enrollment to double to 24 million since they were put in place in 2021.

The federal government has been shut down since October 1 because of a congressional impasse over healthcare. The U.S. Senate moved forward on Sunday on a measure aimed at reopening the federal government and ending the 40-day shutdown.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AtlasClear Files Prospectus for Secondary Offering
AtlasClear Files Prospectus for Secondary Offering
May 14, 2024
11:15 AM EDT, 05/14/2024 (MT Newswires) -- AtlasClear Holdings ( ATCH ) on Tuesday filed a registration statement with the US Securities and Exchange Commission covering the potential sale of its common stock up to a total of roughly 37.9 million shares by selling shareholders from time to time in one or more offerings. The company said it will not...
Cheetah Net Supply Chain Service Shares Surge After Pricing of Follow-On Offering
Cheetah Net Supply Chain Service Shares Surge After Pricing of Follow-On Offering
May 14, 2024
11:19 AM EDT, 05/14/2024 (MT Newswires) -- Cheetah Net Supply Chain Service ( CTNT ) shares surged more than 260% in recent trading Tuesday after the company priced its follow-on offering of about 13.2 million common shares at $0.62 apiece. Gross proceeds from the offering will amount to nearly $8.2 million, according to the company. Net proceeds from the offering...
Promoter group to sell stake worth $316 million in India's Cipla, CNBC-TV18 reports
Promoter group to sell stake worth $316 million in India's Cipla, CNBC-TV18 reports
May 14, 2024
BENGALURU, May 14 (Reuters) - Cipla's promoter group is looking to sell a 2.53% stake in India's third-largest drugmaker via a block deal worth 26.37 billion rupees (nearly $316 million), CNBC-TV18 reported on Tuesday, citing sources. The promoter group will sell its stake in Cipla at a per-share price range of 1,289.5 rupees to 1,357.35 rupees, the report said. The...
Insulet Shares Rise Despite Blue Orca's Short Position
Insulet Shares Rise Despite Blue Orca's Short Position
May 14, 2024
11:19 AM EDT, 05/14/2024 (MT Newswires) -- Insulet ( PODD ) shares were advancing by 5.7% in recent Tuesday trading despite short-seller Blue Orca Capital saying it had taken a short position on the stock. The firm alleged in a report that Insulet ( PODD ) has failed to disclose material information about an appellate court's recent decision to kill...
Copyright 2023-2026 - www.financetom.com All Rights Reserved